Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide

Contact Research Centre

Epileptic encephalopathy

Recruiting

Investigational

Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Epilepsy

Recruiting

Investigational

Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

Investigational

The Netherlands

Participants:0–17 years
Substances:Cannabidiol

Contact Research Centre

Partial seizures

Not yet recruiting

Investigational

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bhv-7000

Contact Research Centre

Epileptic encephalopathy

Not recruiting

Investigational

Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Severe myoclonic epilepsy of infancy

Not recruiting

Investigational

Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Narcolepsy

Not recruiting

Investigational

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide

Contact Research Centre

Partial seizures

Not recruiting

Registered drug

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ivermectin

Contact Research Centre

Narcolepsy

Not recruiting

Investigational

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Find therapies in clinical trials near you

10 trials match your criteria

Partial seizures

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

Narcolepsy

Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Epileptic encephalopathy

Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

Epilepsy

Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

Partial seizures

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Epileptic encephalopathy

Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

Severe myoclonic epilepsy of infancy

Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

Narcolepsy

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Partial seizures

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Narcolepsy

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.